STTK
Price
$0.99
Change
+$0.14 (+16.47%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
45.36M
35 days until earnings call
VRTX
Price
$483.26
Change
-$1.48 (-0.31%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
124.48B
28 days until earnings call
Ad is loading...

STTK vs VRTX

Header iconSTTK vs VRTX Comparison
Open Charts STTK vs VRTXBanner chart's image
Shattuck Labs
Price$0.99
Change+$0.14 (+16.47%)
Volume$1.66K
Capitalization45.36M
Vertex Pharmaceuticals
Price$483.26
Change-$1.48 (-0.31%)
Volume$13.98K
Capitalization124.48B
STTK vs VRTX Comparison Chart
Loading...
STTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
STTK vs. VRTX commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STTK is a Buy and VRTX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (STTK: $0.85 vs. VRTX: $484.74)
Brand notoriety: STTK and VRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: STTK: 97% vs. VRTX: 87%
Market capitalization -- STTK: $45.36M vs. VRTX: $124.48B
STTK [@Biotechnology] is valued at $45.36M. VRTX’s [@Biotechnology] market capitalization is $124.48B. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STTK’s FA Score shows that 1 FA rating(s) are green whileVRTX’s FA Score has 3 green FA rating(s).

  • STTK’s FA Score: 1 green, 4 red.
  • VRTX’s FA Score: 3 green, 2 red.
According to our system of comparison, VRTX is a better buy in the long-term than STTK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STTK’s TA Score shows that 4 TA indicator(s) are bullish while VRTX’s TA Score has 5 bullish TA indicator(s).

  • STTK’s TA Score: 4 bullish, 6 bearish.
  • VRTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VRTX is a better buy in the short-term than STTK.

Price Growth

STTK (@Biotechnology) experienced а -28.92% price change this week, while VRTX (@Biotechnology) price change was -4.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.91%. For the same industry, the average monthly price growth was -7.11%, and the average quarterly price growth was -11.65%.

Reported Earning Dates

STTK is expected to report earnings on May 07, 2025.

VRTX is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-4.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRTX($124B) has a higher market cap than STTK($45.4M). VRTX YTD gains are higher at: 20.372 vs. STTK (-30.091). VRTX has higher annual earnings (EBITDA): 486M vs. STTK (-76.01M). VRTX has more cash in the bank: 6.12B vs. STTK (90.1M). STTK has less debt than VRTX: STTK (3.62M) vs VRTX (1.75B). VRTX has higher revenues than STTK: VRTX (11B) vs STTK (6.44M).
STTKVRTXSTTK / VRTX
Capitalization45.4M124B0%
EBITDA-76.01M486M-16%
Gain YTD-30.09120.372-148%
P/E RatioN/A32.76-
Revenue6.44M11B0%
Total Cash90.1M6.12B1%
Total Debt3.62M1.75B0%
FUNDAMENTALS RATINGS
VRTX: Fundamental Ratings
VRTX
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
14
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
28
P/E GROWTH RATING
1..100
28
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
STTKVRTX
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
52%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
52%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
44%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 17 days ago
61%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
43%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
61%
View a ticker or compare two or three
Ad is loading...
STTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FET20.730.62
+3.08%
Forum Energy Technologies
TPB59.830.39
+0.66%
Turning Point Brands
IT413.72-6.02
-1.43%
Gartner
PCVX32.23-5.53
-14.65%
Vaxcyte
GDHG0.54-4.15
-88.48%
Golden Heaven Group Holdings Ltd

STTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STTK has been loosely correlated with ACAD. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if STTK jumps, then ACAD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STTK
1D Price
Change %
STTK100%
-10.97%
ACAD - STTK
39%
Loosely correlated
-1.75%
LSB - STTK
38%
Loosely correlated
-2.04%
VRTX - STTK
36%
Loosely correlated
-0.02%
ADCT - STTK
35%
Loosely correlated
-4.26%
GOSS - STTK
31%
Poorly correlated
-9.61%
More

VRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRTX has been loosely correlated with CCCC. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if VRTX jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRTX
1D Price
Change %
VRTX100%
-0.02%
CCCC - VRTX
39%
Loosely correlated
-10.31%
STTK - VRTX
37%
Loosely correlated
-10.97%
REGN - VRTX
35%
Loosely correlated
-2.72%
TECH - VRTX
34%
Loosely correlated
-2.18%
KRYS - VRTX
34%
Loosely correlated
-3.17%
More